---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-25-000133"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T13:35:55.225496+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Court grants preliminary approval of $15M derivative suit settlement; final hearing Aug 6

## Summary
- Settlement covers five derivative actions alleging breach of fiduciary duty over Bayview vaccine manufacturing failures.
- Insurers to pay $15M to Emergent; no admission of fault or liability by any defendant.
- Board to adopt corporate governance reforms addressing manufacturing oversight and regulatory compliance.
- Final approval hearing scheduled for August 6, 2025 in U.S. District Court for Maryland.

## SEC filing metadata
- accession: 0001367644-25-000133
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000133/0001367644-25-000133-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764425000133/ebs-20250523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-25-000133
- JSON: https://secwatch.observer/filing/0001367644-25-000133.json
- Plain text: https://secwatch.observer/filing/0001367644-25-000133.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.